NB
NovaBridge Biosciences
NBP · NASDAQ
$1.59 -6.74% (-$0.11)
1M -16.32%
Market Cap $90.2M
P/E Ratio -
Div. Yield -
ROE 0.59%
Piotroski F-Score Weak
1/9Valuation
71 /100
Cheap P/B 2.73x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 94.82%
ROE 0.59%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 8.09x
Int. coverage N/A
Stability
33 /100
Unstable Beta 1.50x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Srishti Gupta
Employees
30
Headquarters
Rockville
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report
31 MAR.
Earnings
Upcoming earnings report